Three drug makers seek bigger market share

Three pharmaceutical firms SK Chemical, Pacific Pharm and Jeil Pharm are gearing up to boost its marketing activities in the domestic cataplaster market showing a sluggish trend, apparently perturbed by growing number of doctors who avoid prescribing cataplasters in fear of non-reimbursement.

Currently, the national health insurance does not cover cataplasma preparations in patients withou...